GB1431841A - Ophthalmic-nutritional preparations - Google Patents
Ophthalmic-nutritional preparationsInfo
- Publication number
- GB1431841A GB1431841A GB204373A GB204373A GB1431841A GB 1431841 A GB1431841 A GB 1431841A GB 204373 A GB204373 A GB 204373A GB 204373 A GB204373 A GB 204373A GB 1431841 A GB1431841 A GB 1431841A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vitamin
- acid
- preparations
- opthalmic
- international units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 3
- 229960003512 nicotinic acid Drugs 0.000 abstract 3
- 235000001968 nicotinic acid Nutrition 0.000 abstract 3
- 239000011664 nicotinic acid Substances 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 abstract 2
- 235000015097 nutrients Nutrition 0.000 abstract 2
- 235000019161 pantothenic acid Nutrition 0.000 abstract 2
- 239000011713 pantothenic acid Substances 0.000 abstract 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 2
- 229960002477 riboflavin Drugs 0.000 abstract 2
- 235000019155 vitamin A Nutrition 0.000 abstract 2
- 239000011719 vitamin A Substances 0.000 abstract 2
- 235000019154 vitamin C Nutrition 0.000 abstract 2
- 239000011718 vitamin C Substances 0.000 abstract 2
- 235000019165 vitamin E Nutrition 0.000 abstract 2
- 239000011709 vitamin E Substances 0.000 abstract 2
- 229940011671 vitamin b6 Drugs 0.000 abstract 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract 1
- 239000004743 Polypropylene Substances 0.000 abstract 1
- FCASKLHVRFDIJB-UHFFFAOYSA-N Riboflavine Natural products Cc1cc2N=C3C(NC(=O)NC3=O)N(CC(O)C(O)C(O)CO)c2cc1C FCASKLHVRFDIJB-UHFFFAOYSA-N 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- 229930003270 Vitamin B Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 229960002562 calcium glucoheptonate Drugs 0.000 abstract 1
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 abstract 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 abstract 1
- 229960002401 calcium lactate Drugs 0.000 abstract 1
- 239000001527 calcium lactate Substances 0.000 abstract 1
- 235000011086 calcium lactate Nutrition 0.000 abstract 1
- 229960002079 calcium pantothenate Drugs 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 235000000639 cyanocobalamin Nutrition 0.000 abstract 1
- 239000011666 cyanocobalamin Substances 0.000 abstract 1
- 229960002104 cyanocobalamin Drugs 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 229940095463 folic acid 0.5 mg Drugs 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 abstract 1
- 229960000367 inositol Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 235000019175 phylloquinone Nutrition 0.000 abstract 1
- 239000011772 phylloquinone Substances 0.000 abstract 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 abstract 1
- 229960001898 phytomenadione Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 235000008160 pyridoxine Nutrition 0.000 abstract 1
- 239000011677 pyridoxine Substances 0.000 abstract 1
- 235000020944 retinol Nutrition 0.000 abstract 1
- 239000011607 retinol Substances 0.000 abstract 1
- 229960003471 retinol Drugs 0.000 abstract 1
- 239000002151 riboflavin Substances 0.000 abstract 1
- 235000019192 riboflavin Nutrition 0.000 abstract 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 235000019157 thiamine Nutrition 0.000 abstract 1
- 239000011721 thiamine Substances 0.000 abstract 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1431841 Opthalmic-nutritional preparations S C EVANS 14 Sept 1973 [15 Jan 1973] 2043/ 73 Heading A5B Opthalmic-nutritional preparations to be used independent of or in conjunction with orthoptic therapy which may be in tablet, powder, capsule or liquid form, as an injectable, suppository or as an eye lotion or drop or other pharmaceutical preparations, contain the following nutrients substantially in the following relative quantities per unit dose viz. (a) vitamin A or Retinol 10000 to 60000 international units, (b) Vitamin B, or Thiamine 0.5 mg, (c) Vitamin B2 or Riboflavine 0.5 mg, (d) Vitamin B6 or Pyridoxine 0.5 mg, (e) Vitamin B12 or Cyanocobalamin 0.5 mcg, (f) Vitamin C or ascorbic acid 125 to 2000 mg, (g) Vitamin D or Ergocalciferal 1000 international units, (h) Vitamin E or alpha-tocopheryl 25 to 200 mg, (i) Vitamin K phytomenadione or mendrol sodium diphosphate 1 mg, (j) Folic acid 0.5 mg, (k) Pantothenic acid 5.0 mg, (1) Niacin or Nicotinic acid 7.5 to 20 mg, (m) Para-amino benzoic acid 10 mg, (n) Calcium lactate, Glucoheptonate or pantothenate 200 to 2000 mg, (o) Choline 250 mg, to be taken together with the patient's existing diet. The preparations may be combined with inositol, glucose, additional nutrients and/or minerals e.g. Vitamins A, C, E or PP (nicotinic acid), and/or protein such as dried yeast or milk.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB204373A GB1431841A (en) | 1973-01-15 | 1973-01-15 | Ophthalmic-nutritional preparations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB204373A GB1431841A (en) | 1973-01-15 | 1973-01-15 | Ophthalmic-nutritional preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1431841A true GB1431841A (en) | 1976-04-14 |
Family
ID=9732617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB204373A Expired GB1431841A (en) | 1973-01-15 | 1973-01-15 | Ophthalmic-nutritional preparations |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1431841A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4657930A (en) * | 1981-10-09 | 1987-04-14 | Baylor College Of Medicine | Mitotic inhibitors preventing posterior lens capsule opacification |
| US4826871A (en) * | 1985-03-13 | 1989-05-02 | Gressel Philip D | Topical ophthalmic compositions containing one or more retinoids |
| WO1990008548A1 (en) * | 1989-02-02 | 1990-08-09 | Senju Pharmaceutical Co., Ltd. | Liquid preparation for intraocular perfusion |
| US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
| US5017564A (en) * | 1988-06-03 | 1991-05-21 | Senju Pharmaceutical Co., Ltd. | Solid pharmaceutical preparation and method of producing same |
| US5032392A (en) * | 1986-09-04 | 1991-07-16 | Vision Pharmaceuticals | Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes |
| WO1992017173A3 (en) * | 1991-04-02 | 1993-01-07 | Jean Berque | Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
| EP0330583B1 (en) * | 1988-02-26 | 1993-08-18 | L'oreal | Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application |
| EP0595006A1 (en) | 1992-09-14 | 1994-05-04 | Vesta Medicines (Proprietary) Limited | Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
| EP0862916A4 (en) * | 1995-11-20 | 2001-01-10 | Kiyoshi Kita | External preparation containing vitamin d or vitamin k |
| WO2008086270A3 (en) * | 2007-01-05 | 2009-08-27 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
| US9308264B2 (en) | 2000-11-08 | 2016-04-12 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
| EP3130335A1 (en) * | 2015-08-13 | 2017-02-15 | Sooft Italia Spa | Ophthalmic composition comprising inositol for improving visual accomodation |
-
1973
- 1973-01-15 GB GB204373A patent/GB1431841A/en not_active Expired
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4657930A (en) * | 1981-10-09 | 1987-04-14 | Baylor College Of Medicine | Mitotic inhibitors preventing posterior lens capsule opacification |
| US4826871A (en) * | 1985-03-13 | 1989-05-02 | Gressel Philip D | Topical ophthalmic compositions containing one or more retinoids |
| US5032392A (en) * | 1986-09-04 | 1991-07-16 | Vision Pharmaceuticals | Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes |
| US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
| EP0330583B1 (en) * | 1988-02-26 | 1993-08-18 | L'oreal | Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application |
| US5017564A (en) * | 1988-06-03 | 1991-05-21 | Senju Pharmaceutical Co., Ltd. | Solid pharmaceutical preparation and method of producing same |
| WO1990008548A1 (en) * | 1989-02-02 | 1990-08-09 | Senju Pharmaceutical Co., Ltd. | Liquid preparation for intraocular perfusion |
| WO1992017173A3 (en) * | 1991-04-02 | 1993-01-07 | Jean Berque | Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
| EP0595006A1 (en) | 1992-09-14 | 1994-05-04 | Vesta Medicines (Proprietary) Limited | Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
| EP0862916A4 (en) * | 1995-11-20 | 2001-01-10 | Kiyoshi Kita | External preparation containing vitamin d or vitamin k |
| US9308264B2 (en) | 2000-11-08 | 2016-04-12 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
| US9585394B2 (en) | 2000-11-08 | 2017-03-07 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
| US10064410B2 (en) | 2000-11-08 | 2018-09-04 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
| US10595532B2 (en) | 2000-11-08 | 2020-03-24 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
| WO2008086270A3 (en) * | 2007-01-05 | 2009-08-27 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
| EP3130335A1 (en) * | 2015-08-13 | 2017-02-15 | Sooft Italia Spa | Ophthalmic composition comprising inositol for improving visual accomodation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1431841A (en) | Ophthalmic-nutritional preparations | |
| ZA888461B (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
| SUYCHINOV et al. | Vitamins and their role in human body. | |
| CN101780100B (en) | Water-soluble vitamin composition for injection and preparation method thereof | |
| GB1437133A (en) | Method for the treatment of ketosis and osteomalacia in cattle | |
| Cott | Medicinal plants and dietary supplements: Sources for innovative treatments or adjuncts? | |
| US20160038530A1 (en) | Nutritional Supplement to Complement Cancer Therapy | |
| US10695369B2 (en) | Cognitive function-remedying agent | |
| CN102579956B (en) | Medicament composition and application thereof | |
| Paul et al. | Urinary cyclic AMP in affective illness | |
| Kier et al. | Blood and urine levels in glutethimide (Doriden) intoxication | |
| GHITIS et al. | Availability of milk folate: Studies with cow’s milk in experimental folic acid deficiency | |
| IE37291L (en) | Mineral salt preparation | |
| JP4553552B2 (en) | Biorhythm application kit | |
| GB1246315A (en) | Pharmaceutical compositions | |
| RIVAS et al. | The oral administration of vitamin B12 in tropical sprue | |
| Smith et al. | Role of Spirulina in Anemia Management and Hematopoiesis | |
| Alexandrovna et al. | Study of physicochemical properties of the preparation from the bursa of Fabricius of broiler chickens | |
| DWIVEDI et al. | Multivitamin Supplements: A Market Analyisis. | |
| Tablets | Mugastral Tablets | |
| Pedrazzoli et al. | Response to recombinant human erythropoietin (rHuEpo) in patients with cancer-related anaemia | |
| Dedić et al. | PHARMACEUTICAL FORMS OF IRON IN FOOD SUPPLEMENTS | |
| Berk et al. | reported positive hematologic response in 3 patients | |
| Suárez Sr et al. | The effect of orally administered folinic acid in the treatment of tropical sprue | |
| KR102180165B1 (en) | A synergistic composition for treating anemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 19930913 |